Zobrazeno 1 - 10
of 100
pro vyhledávání: '"David L, Grinblatt"'
Publikováno v:
Case Reports in Hematology, Vol 2023 (2023)
In this case, we describe the potential risk of developing an infectious complication leading to a secondary malignancy after a short course of immunotherapy. We report a patient who presented with Epstein–Barr virus (EBV) driven Hodgkin’s lympho
Externí odkaz:
https://doaj.org/article/dde51a12d50a4430a52b4c45f31aa92b
Autor:
Jeff P. Sharman, Kim Cocks, Chadi Nabhan, Nicole Lamanna, Neil E. Kay, David L. Grinblatt, Christopher R. Flowers, Matthew S. Davids, Pavel Kiselev, Arlene S. Swern, Kristen Sullivan, Mecide M. Gharibo, E. Dawn Flick, Andrew Trigg, Anthony Mato
Publikováno v:
eJHaem, Vol 1, Iss 1, Pp 188-198 (2020)
Abstract Health‐related quality of life (HRQoL) in patients with chronic lymphocytic leukemia (CLL) is important in guiding treatment decisions. However, the impact of CLL treatment initiation on HRQoL is unclear. We assessed HRQoL using the FACT
Externí odkaz:
https://doaj.org/article/34c06b8e749f4507ab23a49de144c417
Autor:
Daniel A. Pollyea, Tracy I. George, Mehrdad Abedi, Rafael Bejar, Christopher R. Cogle, Kathryn Foucar, Guillermo Garcia‐Manero, David L. Grinblatt, Rami S. Komrokji, Jaroslaw P. Maciejewski, Dennis A. Revicki, Gail J. Roboz, Michael R. Savona, Bart L. Scott, Mikkael A. Sekeres, Michael A. Thompson, Sandra E. Kurtin, Chrystal U. Louis, Melissa Nifenecker, E. Dawn Flick, Arlene S. Swern, Pavel Kiselev, David P. Steensma, Harry P. Erba
Publikováno v:
eJHaem, Vol 1, Iss 1, Pp 58-68 (2020)
Abstract Diagnostic and molecular genetic testing are key in advancing the treatment of acute myeloid leukemia (AML), yet little is known about testing patterns outside of clinical trials, especially in older patients. We analyzed diagnostic and mole
Externí odkaz:
https://doaj.org/article/b36efed85da84efcbaf5ae149d394d44
Autor:
Benjamin A. Derman, Ankit Kansagra, Jeffrey Zonder, Andrew T. Stefka, David L. Grinblatt, Larry D. Anderson, Sandeep Gurbuxani, Sunil Narula, Shayan Rayani, Ajay Major, Andrew Kin, Ken Jiang, Theodore Karrison, Jagoda Jasielec, Andrzej J. Jakubowiak
Publikováno v:
JAMA oncology. 8(9)
ImportanceTreatment of newly diagnosed multiple myeloma (NDMM) with a quadruplet regimen consisting of a monoclonal antibody, proteasome inhibitor, immunomodulatory imide, and corticosteroid has been associated with improved progression-free survival
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e5c3a0fae97715447317653be822edc
https://pubmed.ncbi.nlm.nih.gov/35862054
https://pubmed.ncbi.nlm.nih.gov/35862054
Autor:
Inhye E. Ahn, Charles M. Farber, Matthew S. Davids, David L. Grinblatt, Neil E. Kay, Nicole Lamanna, Anthony Mato, Chadi Nabhan, Pavel Kiselev, Arlene S. Swern, E. Dawn Flick, Kristen Sullivan, Jeff P. Sharman, Christopher R. Flowers
Publikováno v:
Blood Advances, Vol 1, Iss 25, Pp 2433-2443 (2017)
Abstract: Chemoimmunotherapy for chronic lymphocytic leukemia (CLL) promotes clonal evolution of aggressive clones, which in some patients may lead to early progression of disease (POD). We studied the prognostic value of early POD in a cohort of pat
Externí odkaz:
https://doaj.org/article/f151c5319e37462ba900987b62bc8361
Autor:
Benjamin Tomlinson, Marcos de Lima, Christopher R. Cogle, Michael A. Thompson, David L. Grinblatt, Daniel A. Pollyea, Rami S. Komrokji, Gail J. Roboz, Michael R. Savona, Mikkael A. Sekeres, Mehrdad Abedi, Guillermo Garcia-Manero, Sandra E. Kurtin, Jaroslaw P. Maciejewski, Jay L. Patel, Dennis A. Revicki, Tracy I. George, E. Dawn Flick, Pavel Kiselev, Chrystal U. Louis, Irene S. DeGutis, Melissa Nifenecker, Harry P. Erba, David P. Steensma, Bart L. Scott
Publikováno v:
Transplantation and Cellular Therapy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::596436d84ba44c48c9839e040b820064
https://doi.org/10.1016/j.jtct.2023.04.011
https://doi.org/10.1016/j.jtct.2023.04.011
Autor:
Amer M. Zeidan, Santosh Gautam, Rebekah Yu, Ziyu Lan, David L. Grinblatt, Dina ElSouda, James Spalding, Alana Block, Maelys Touya, Bhavik J. Pandya
Publikováno v:
Blood. 140:8124-8126
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aaf078c603e6554c004531a6d01e6fca
https://doi.org/10.1182/blood-2022-166692
https://doi.org/10.1182/blood-2022-166692
Autor:
Mikkael A. Sekeres, Guillermo Garcia-Manero, David L. Grinblatt, Rami S. Komrokji, Michael R. Savona, Harry P. Erba, Gail J. Roboz, Irene S. DeGutis, Pavel Kiselev, Edward Yu, Adeola Y. Makinde, Ali McBride, Bart L. Scott
Publikováno v:
Blood. 140:9818-9820
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0fe90dd879905ff929b67e7143111a43
https://doi.org/10.1182/blood-2022-158075
https://doi.org/10.1182/blood-2022-158075
Autor:
Arlene S. Swern, Michael R. Savona, Rami S. Komrokji, David L. Grinblatt, Dennis A. Revicki, Guillermo Garcia-Manero, Melissa Nifenecker, Jaroslaw P. Maciejewski, Pavel Kiselev, Mehrdad Abedi, Bart L. Scott, David P. Steensma, Elizabeth Dawn Flick, Chrystal U. Louis, Christopher R. Cogle, Michael A. Thompson, Jay Patel, Gail J. Roboz, Kathryn Foucar, Harry P. Erba, Mikkael A. Sekeres, Tracy I. George, Daniel A. Pollyea, Sandra E. Kurtin
Publikováno v:
International Journal of Laboratory Hematology
Introduction The presence of ring sideroblasts (RS) and mutation of the SF3B1 gene are diagnostic of lower‐risk (LR) myelodysplastic syndromes (MDS) and are correlated with favorable outcomes. However, information on testing and reporting in commun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e06a260140427434697efc1587dcbddc
https://doi.org/10.1111/ijlh.13400
https://doi.org/10.1111/ijlh.13400
Autor:
Arlene S. Swern, Chadi Nabhan, E. Dawn Flick, David L. Grinblatt, Christopher R. Flowers, Neil E. Kay, Kim Cocks, Anthony R. Mato, Nicole Lamanna, Kristen A. Sullivan, Matthew S. Davids, Andrew Trigg, Pavel Kiselev, Mecide Gharibo, Jeff P. Sharman
Publikováno v:
eJHaem. 1:188-198
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::15b200688fc1a2c475f29afb31ae8c2a
https://doi.org/10.1002/jha2.67
https://doi.org/10.1002/jha2.67